Real-time enrollment status for this diabetic macular edema clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:24 PM UTC
| NCT Number | NCT07553429 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema |
| Phase | PHASE1 |
| Target Enrollment | 49 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | September 30, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07553429 is currently recruiting participants. This phase1 study for diabetic macular edema is actively seeking new participants at 28 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07553429 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07553429 was last updated 1 week ago (September 30, 2026). HelloStudys verifies this status automatically.